Capital Fund Management (CFM)
CLVS

Capital Fund Management (CFM)’s Clovis Oncology, Inc. CLVS Stock Holding History

Capital Fund Management (CFM)’s Portfolio CLVS Stock Details CLVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-155,285
Closed -$1.05M – 1434
2020
Q2 		$1.05M Buy
155,285
+132,400
+579% +$1M 0.02% 681
2020
Q1 		$146K Buy
+22,885
New +$184K ﹤0.01% 1450
2018
Q3 		– Sell
-35,524
Closed -$1.61M – 2357
2018
Q2 		$1.61M Buy
+35,524
New +$1.73M 0.01% 1166
2018
Q1 		– Sell
-50,471
Closed -$3.43M – 2275
2017
Q4 		$3.43M Buy
50,471
+36,472
+261% +$2.55M 0.02% 802
2017
Q3 		$1.15M Sell
13,999
-29,159
-68% -$2.31M 0.01% 915
2017
Q2 		$4.04M Buy
43,158
+33,125
+330% +$2.03M 0.03% 532
2017
Q1 		$639K Buy
+10,033
New +$610K 0.01% 1065
2015
Q1 		– Sell
-58,712
Closed -$3.29M – 1810
2014
Q4 		$3.29M Buy
+58,712
New +$3.09M 0.04% 547
2014
Q3 		– Sell
-74,635
Closed -$3.09M – 1898
2014
Q2 		$3.09M Buy
74,635
+70,481
+1,697% +$3.63M 0.03% 577
2014
Q1 		$288K Buy
+4,154
New +$305K ﹤0.01% 1496

Other funds holding CLVS

State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
CS
Candriam SCA Strassen, Luxembourg, Luxembourg $19.3B AUM 39.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital Fund Management (CFM)'s CLVS Position: Q3 2020 in Review

Capital Fund Management (CFM) sold out of Clovis Oncology, Inc. (CLVS) in Q3 2020, closing a stake of 155,285 shares — an estimated $1.05M sold.

Capital Fund Management (CFM) first reported a position in CLVS in Q1 2014 and held it in 10 quarters. The position peaked at $4.04M in Q2 2017. 169 funds tracked by Wall St. Rank hold CLVS as of Q3 2020.

  • Capital Fund Management (CFM) reported no remaining Clovis Oncology, Inc. position as of Q3 2020 after selling out during the quarter.
  • Capital Fund Management (CFM) sold 155,285 Clovis Oncology, Inc. shares in Q3 2020, an estimated $1.05M.
  • Capital Fund Management (CFM) first reported a position in Clovis Oncology, Inc. in Q1 2014 and held it in 10 quarters.
  • Capital Fund Management (CFM)'s Clovis Oncology, Inc. position peaked at $4.04M in Q2 2017.
  • 169 funds tracked by Wall St. Rank held Clovis Oncology, Inc. as of Q3 2020.

Based on Capital Fund Management (CFM)'s 13F filing for Q3 2020, filed 13 Nov 2020.